IL239450B - Sulfate salts of n-(3-(4-(3-diisobutylamino)propyl)piperazine-1-yl)propyl)-h1-benzo[d]imidazol-2-amine, their preparation and use - Google Patents

Sulfate salts of n-(3-(4-(3-diisobutylamino)propyl)piperazine-1-yl)propyl)-h1-benzo[d]imidazol-2-amine, their preparation and use

Info

Publication number
IL239450B
IL239450B IL239450A IL23945015A IL239450B IL 239450 B IL239450 B IL 239450B IL 239450 A IL239450 A IL 239450A IL 23945015 A IL23945015 A IL 23945015A IL 239450 B IL239450 B IL 239450B
Authority
IL
Israel
Prior art keywords
propyl
diisobutylamino
piperazin
imidazol
benzo
Prior art date
Application number
IL239450A
Other languages
English (en)
Hebrew (he)
Other versions
IL239450A0 (en
Original Assignee
Inst Nat Sante Rech Med
Alzprotect
Univ Lille Ii Droit & Sante
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Alzprotect, Univ Lille Ii Droit & Sante filed Critical Inst Nat Sante Rech Med
Publication of IL239450A0 publication Critical patent/IL239450A0/en
Publication of IL239450B publication Critical patent/IL239450B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL239450A 2012-12-27 2015-06-16 Sulfate salts of n-(3-(4-(3-diisobutylamino)propyl)piperazine-1-yl)propyl)-h1-benzo[d]imidazol-2-amine, their preparation and use IL239450B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP12306690 2012-12-27
PCT/EP2013/078068 WO2014102339A1 (en) 2012-12-27 2013-12-27 Sulphate salts of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine, preparation thereof and use of the same

Publications (2)

Publication Number Publication Date
IL239450A0 IL239450A0 (en) 2015-07-30
IL239450B true IL239450B (en) 2018-06-28

Family

ID=47501005

Family Applications (1)

Application Number Title Priority Date Filing Date
IL239450A IL239450B (en) 2012-12-27 2015-06-16 Sulfate salts of n-(3-(4-(3-diisobutylamino)propyl)piperazine-1-yl)propyl)-h1-benzo[d]imidazol-2-amine, their preparation and use

Country Status (23)

Country Link
US (3) US9562018B2 (enExample)
EP (1) EP2938597B1 (enExample)
JP (1) JP6384923B2 (enExample)
KR (1) KR102115060B1 (enExample)
CN (1) CN105008333B (enExample)
AU (2) AU2013369288B2 (enExample)
BR (1) BR112015015474B1 (enExample)
CA (1) CA2895285C (enExample)
DK (1) DK2938597T3 (enExample)
ES (1) ES2605494T3 (enExample)
HR (1) HRP20161612T2 (enExample)
HU (1) HUE030930T2 (enExample)
IL (1) IL239450B (enExample)
LT (1) LT2938597T (enExample)
MX (1) MX363367B (enExample)
NZ (1) NZ708959A (enExample)
PL (1) PL2938597T3 (enExample)
PT (1) PT2938597T (enExample)
RS (1) RS55511B1 (enExample)
RU (1) RU2655454C2 (enExample)
SI (1) SI2938597T1 (enExample)
WO (1) WO2014102339A1 (enExample)
ZA (1) ZA201504521B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS55511B1 (sr) * 2012-12-27 2017-05-31 Alzprotect Sulfatne soli n-(3-(4-(3-(diizobutilamino)propil)piperazin-1-il)propil)-1h-benzo[d]imidazol-2-amina, njihova priprema i upotreba
WO2016146655A1 (en) 2015-03-16 2016-09-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Novel 1,4-bis(3-aminopropyl)piperazine derivative and its use
TWI744300B (zh) * 2016-03-23 2021-11-01 里爾中央醫學中心 改良性熱處理的血小板顆粒裂解液在製備用於治療神經系統疾病的組合物的用途
CN116249693A (zh) * 2020-10-01 2023-06-09 雅尔兹普罗泰特公司 N-(3-(4-(3-(二异丁基氨基)丙基)哌嗪-1-基)丙基)-1H-苯并[d]咪唑-2-胺的琥珀酸盐，其制备及其用途
DK4225306T3 (da) * 2020-10-07 2025-03-24 Alzprotect Anvendelse af n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-aminsulfatsalte og solvater heraf til behandling af motorneuronsygdomme og neuromuskulære forbindelseslidelser
MX2024007691A (es) 2021-12-20 2024-07-01 Alzprotect Uso de sales de succinato de n-(3-(4-(3-(diisobutilamino)propil)pi perazin-1-il)propil)-1h-benzo[d]imidazol-2-amina y solvatos del mismo para el tratamiento de enfermedades de las neuronas motoras y trastornos de la union neuromuscular.
US20250205226A1 (en) 2022-03-25 2025-06-26 Alzprotect Use of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine salts and solvates thereof for the treatment of sensory neuron diseases

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2674856B1 (fr) * 1991-04-05 1993-07-30 Esteve Labor Dr Nouveaux antihistaminiques non sedatifs, derives de benzimidazole, leur procede de preparation et leur utilisation en tant que medicaments.
WO1998056423A1 (fr) * 1997-06-12 1998-12-17 Transgene S.A. Nouveaux complexes lipidiques pour le transfert d'au moins une substance therapeutiquement active, notamment un polynucleotide, dans une cellule cible et utilisation en therapie genique
HK1038749A1 (zh) 1998-09-30 2002-03-28 纽罗根公司 2-哌嗪烷基氨苯并吡咯衍生物:多巴胺受体亚型特异配体
WO2002096431A1 (en) * 2001-05-25 2002-12-05 The Regents Of The University Of California Optically active compounds clearing malformed proteins
US20040116441A1 (en) * 2002-10-30 2004-06-17 Pfizer Inc Methods of using sulfonic acid derivatives
EP1581517B1 (en) * 2002-12-23 2007-02-21 Janssen Pharmaceutica N.V. Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
ATE524181T1 (de) * 2004-11-10 2011-09-15 Inst Nat Sante Rech Med Verwendung von 1,4-bis (3-aminoalkyl) piperazin- derivaten bei der behandlung von neurodegenerativen erkrankungen
RS55511B1 (sr) * 2012-12-27 2017-05-31 Alzprotect Sulfatne soli n-(3-(4-(3-(diizobutilamino)propil)piperazin-1-il)propil)-1h-benzo[d]imidazol-2-amina, njihova priprema i upotreba

Also Published As

Publication number Publication date
US20170151235A1 (en) 2017-06-01
US20190381036A1 (en) 2019-12-19
AU2013369288A8 (en) 2015-07-16
HUE030930T2 (hu) 2017-06-28
DK2938597T3 (en) 2017-01-09
US9562018B2 (en) 2017-02-07
ZA201504521B (en) 2016-11-30
NZ708959A (en) 2019-11-29
SI2938597T1 (sl) 2017-03-31
HRP20161612T2 (hr) 2017-02-24
MX2015008502A (es) 2015-12-16
IL239450A0 (en) 2015-07-30
BR112015015474B1 (pt) 2022-04-19
AU2018202218A1 (en) 2018-04-26
RU2655454C2 (ru) 2018-05-29
BR112015015474A2 (enExample) 2017-08-15
ES2605494T3 (es) 2017-03-14
US20160108003A1 (en) 2016-04-21
US10537569B2 (en) 2020-01-21
CN105008333A (zh) 2015-10-28
HRP20161612T1 (hr) 2017-01-27
US10772884B2 (en) 2020-09-15
KR20150105313A (ko) 2015-09-16
MX363367B (es) 2019-03-20
CA2895285C (en) 2021-03-30
AU2018202218B2 (en) 2019-02-21
EP2938597B1 (en) 2016-10-26
JP6384923B2 (ja) 2018-09-05
LT2938597T (lt) 2017-01-25
RU2015130671A (ru) 2017-01-30
EP2938597A1 (en) 2015-11-04
HK1215582A1 (en) 2016-09-02
AU2013369288B2 (en) 2018-02-22
AU2013369288A1 (en) 2015-07-02
CA2895285A1 (en) 2014-07-03
PL2938597T3 (pl) 2017-03-31
CN105008333B (zh) 2018-02-09
WO2014102339A1 (en) 2014-07-03
RS55511B1 (sr) 2017-05-31
PT2938597T (pt) 2016-12-09
KR102115060B1 (ko) 2020-05-25
JP2016503813A (ja) 2016-02-08

Similar Documents

Publication Publication Date Title
CY2022033I1 (el) Παραγωγα βενζαμιδιου για την αναστολη της δραστικοτητας των abl1, abl2 και bcr-abl1
ZA201504521B (en) Sulphate salts of n-(3-(4-(3-(diisobutylamino)propyl)piperazin-1-yl)propyl)-1h-benzo[d]imidazol-2-amine, preparation thereof and use of the same
HUS2100032I1 (hu) Helyettesített 5-fluor-1H-pirazolopiridin-származékok és alkalmazásuk
ZA201404189B (en) 2-(1,2,3-triazol-2-yl)benzamide and 3-(1,2,3-triazol-2-yl)picolinamide derivatives as orexin receptor antagonists
IL246600B (en) Heterocyclic compounds and their use
EP2637669A4 (en) Heterocyclic compounds and their use
PT2603513T (pt) Composto heterocíclico e sua utilização como modulador alostérico positivo do recetor de ampa
PT2970259T (pt) N-(4-(azaindazol-6-il)-fenil)-sulfonamidas e a sua utilização como fármacos
HRP20160250T1 (hr) Postupak za pripravu 2-(2,3-dimetilfenil)-1-propanala s kloracetonom
IL250606A0 (en) D2 antagonists, methods of synthesis and methods of use
IL225785A0 (en) Heterocyclic compounds, compositions comprising the same and uses thereof
HUE054054T2 (hu) Transz-4-{2-[4-(2,3-diklór-fenil)-piperazin-1-il]-etil}-N,N-dimetilkarbamoil-ciklohexilamin skizofrénia elsõdleges negatív tüneteinek kezelésére
IL232404A0 (en) n-(4-quinolinylmethyl)-sulfonamide derivatives and their use as anthelmintics
PL2608789T5 (pl) Terapeutyczne zastosowania 1-[2-(2,4- dimetylofenylosulfanylo)- fenylo]piperazyny
IL236146A0 (en) N-[4-quinoline-4-yloxy)cyclohexyl(methyl)](hetero)arylcarboxamides as androgen receptor antagonists, their production and use as medicinal products
EP2813508A4 (en) HETEROCYCLIC COMPOUND AND APPLICATION THEREOF
SI2603217T1 (sl) Novi 6,7-disubstituirani-isokinolinski derivati in njihova uporaba
EP2763980A4 (en) BICARBOCYCLIC AND TRICARBOCYCLIC ETHYNYL DERIVATIVES AND USES THEREOF
HK1183813A (en) Ranolazine for use for the treatment of pulmonary hypertension
PL392322A1 (pl) Synton w syntezie rosuwastatyny, sposób otrzymywania syntonu w syntezie rosuwastatyny oraz zastosowanie syntonu w syntezie rosuwastatyny
PL395184A1 (pl) Nowe pochodne benzimidazolu, sposób wytwarzania i zastosowanie pochodnych benzimidazolu

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed